Executive Chairman Tim Donald Johnson of Health In Tech, Inc. filed a Form 4 on November 13, 2026, disclosing seven separate restricted stock acquisitions of Class A and Class B Common Stock totaling 3,050,000 shares, all transacted on November 10, 2026, at $0 per share.
Key Highlights
- Seven restricted stock grants on November 10, 2026: Johnson acquired 2,850,000 shares of Class A Common Stock and 200,000 shares of Class B Common Stock, all at $0 consideration.
- Post-transaction beneficial ownership: Johnson directly holds 26,201,298 shares of Class A Common Stock and 9,200,000 shares of Class B Common Stock following the reported transactions.
- Time-based vesting grant of 650,000 shares: These Class A shares vest in twelve equal monthly installments beginning November 15, 2026, under a Restricted Stock Award Agreement dated October 20, 2026.
- Acquisition milestone grant of 800,000 shares: These Class A shares vest only upon the closing of an acquisition by the issuer on or before December 31, 2028; otherwise they are forfeited without consideration.
- Market capitalization milestone grants: Four separate grants totaling 1,400,000 Class A shares (and 200,000 Class B shares mirroring one tranche) are tied to 10-day VWAP market cap thresholds of $150 million, $300 million, $500 million, and $1 billion, with deadlines ranging from April 30, 2028, to December 31, 2031.
- Stockholder approval required: Grants described in footnote 1 were contingent on stockholder approval of a Plan amendment, which was obtained at the issuer's 2026 Annual Meeting of Stockholders on November 10, 2026.
- Change in Control acceleration: According to the filing, all unvested restricted shares vest in full upon a Change in Control as defined in the Health In Tech, Inc. Equity Incentive Plan.
Johnson's Restricted Stock Awards: Structure and Vesting Conditions
According to the filing, Tim Donald Johnson, who serves as Executive Chairman and is identified as both a director and a 10% owner of Health In Tech, Inc. (NASDAQ:HIT), received seven distinct restricted stock awards on November 10, 2026, all granted at $0 per share under the Health In Tech, Inc. Equity Incentive Plan. The grants span two classes of stock and carry a range of vesting conditions.
The 650,000-share Class A grant follows a time-based schedule, vesting in twelve equal monthly installments starting November 15, 2026, subject to continued service. The 800,000-share Class A grant is contingent solely on the closing of an issuer acquisition on or before December 31, 2028, and is forfeited without consideration if that event does not occur. Four additional grants, totaling 1,400,000 shares of Class A Common Stock, carry performance conditions tied to the issuer's market capitalization measured by 10-day volume-weighted average price: thresholds of $150 million (deadline April 30, 2028), $300 million (deadline December 31, 2028), $500 million (deadline December 31, 2029), and $1 billion (deadline December 31, 2031). A seventh grant of 200,000 Class B Common Stock shares mirrors the $150 million market cap tranche on the same terms.
The filing notes that Johnson's total direct beneficial ownership of Class A Common Stock after all reported transactions stands at 26,201,298 shares, which the filing states includes 3,663,279 restricted shares and 22,538,019 unrestricted shares. Excluded from that figure, according to the filing, are 200,000 restricted shares of Class B Common Stock, 9,000,000 shares of Class B Common Stock, and 734,707 options to purchase Class A shares. The form was signed by Lori Babcock as attorney-in-fact for Tim Johnson and filed November 13, 2026.
What Was Disclosed
Health In Tech, Inc. Executive Chairman Tim Donald Johnson reported seven restricted stock awards totaling 3,050,000 shares across two share classes, all dated November 10, 2026, at $0 per share, with vesting tied to service, an acquisition event, or specific market capitalization milestones.




Please wait processing your request...